Integrase Inhibitors Market, Global Outlook and Forecast 2022-2028

April 2022 | 73 pages | ID: I3EAAD8706E4EN
Market Monitor Global

Abstracts

Integrase inhibitors (INIs) are the most new class of antiretroviral medications to be approved to treat HIV infection. They are quickly becoming standard treatments for both HIV naive and substantially pre-treated patients.

This report contains market size and forecasts of Integrase Inhibitors in global, including the following market information:

Global Integrase Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Integrase Inhibitors Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Integrase Inhibitors companies in 2021 (%)

The global Integrase Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Raltegravir Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Integrase Inhibitors include Merck, GlaxoSmithKline, Hetero Drugs, Mylan, Aurobindo Pharma, Cipla, Laurus Labs, Gilead Sciences and Micro Labs. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Integrase Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Integrase Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Integrase Inhibitors Market Segment Percentages, by Type, 2021 (%)

• Raltegravir
• Dolutegravir
• Elvitegravir
• Bictegravir

Global Integrase Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Integrase Inhibitors Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital

Global Integrase Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Integrase Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Integrase Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Integrase Inhibitors revenues share in global market, 2021 (%)

Key companies Integrase Inhibitors sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Integrase Inhibitors sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• GlaxoSmithKline
• Hetero Drugs
• Mylan
• Aurobindo Pharma
• Cipla
• Laurus Labs
• Gilead Sciences
• Micro Labs

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Integrase Inhibitors Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Integrase Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INTEGRASE INHIBITORS OVERALL MARKET SIZE

2.1 Global Integrase Inhibitors Market Size: 2021 VS 2028
2.2 Global Integrase Inhibitors Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Integrase Inhibitors Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Integrase Inhibitors Players in Global Market
3.2 Top Global Integrase Inhibitors Companies Ranked by Revenue
3.3 Global Integrase Inhibitors Revenue by Companies
3.4 Global Integrase Inhibitors Sales by Companies
3.5 Global Integrase Inhibitors Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Integrase Inhibitors Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Integrase Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Integrase Inhibitors Players in Global Market
  3.8.1 List of Global Tier 1 Integrase Inhibitors Companies
  3.8.2 List of Global Tier 2 and Tier 3 Integrase Inhibitors Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Integrase Inhibitors Market Size Markets, 2021 & 2028
  4.1.2 Raltegravir
  4.1.3 Dolutegravir
  4.1.4 Elvitegravir
  4.1.5 Bictegravir
4.2 By Type - Global Integrase Inhibitors Revenue & Forecasts
  4.2.1 By Type - Global Integrase Inhibitors Revenue, 2017-2022
  4.2.2 By Type - Global Integrase Inhibitors Revenue, 2023-2028
  4.2.3 By Type - Global Integrase Inhibitors Revenue Market Share, 2017-2028
4.3 By Type - Global Integrase Inhibitors Sales & Forecasts
  4.3.1 By Type - Global Integrase Inhibitors Sales, 2017-2022
  4.3.2 By Type - Global Integrase Inhibitors Sales, 2023-2028
  4.3.3 By Type - Global Integrase Inhibitors Sales Market Share, 2017-2028
4.4 By Type - Global Integrase Inhibitors Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Integrase Inhibitors Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
5.2 By Application - Global Integrase Inhibitors Revenue & Forecasts
  5.2.1 By Application - Global Integrase Inhibitors Revenue, 2017-2022
  5.2.2 By Application - Global Integrase Inhibitors Revenue, 2023-2028
  5.2.3 By Application - Global Integrase Inhibitors Revenue Market Share, 2017-2028
5.3 By Application - Global Integrase Inhibitors Sales & Forecasts
  5.3.1 By Application - Global Integrase Inhibitors Sales, 2017-2022
  5.3.2 By Application - Global Integrase Inhibitors Sales, 2023-2028
  5.3.3 By Application - Global Integrase Inhibitors Sales Market Share, 2017-2028
5.4 By Application - Global Integrase Inhibitors Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Integrase Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global Integrase Inhibitors Revenue & Forecasts
  6.2.1 By Region - Global Integrase Inhibitors Revenue, 2017-2022
  6.2.2 By Region - Global Integrase Inhibitors Revenue, 2023-2028
  6.2.3 By Region - Global Integrase Inhibitors Revenue Market Share, 2017-2028
6.3 By Region - Global Integrase Inhibitors Sales & Forecasts
  6.3.1 By Region - Global Integrase Inhibitors Sales, 2017-2022
  6.3.2 By Region - Global Integrase Inhibitors Sales, 2023-2028
  6.3.3 By Region - Global Integrase Inhibitors Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Integrase Inhibitors Revenue, 2017-2028
  6.4.2 By Country - North America Integrase Inhibitors Sales, 2017-2028
  6.4.3 US Integrase Inhibitors Market Size, 2017-2028
  6.4.4 Canada Integrase Inhibitors Market Size, 2017-2028
  6.4.5 Mexico Integrase Inhibitors Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Integrase Inhibitors Revenue, 2017-2028
  6.5.2 By Country - Europe Integrase Inhibitors Sales, 2017-2028
  6.5.3 Germany Integrase Inhibitors Market Size, 2017-2028
  6.5.4 France Integrase Inhibitors Market Size, 2017-2028
  6.5.5 U.K. Integrase Inhibitors Market Size, 2017-2028
  6.5.6 Italy Integrase Inhibitors Market Size, 2017-2028
  6.5.7 Russia Integrase Inhibitors Market Size, 2017-2028
  6.5.8 Nordic Countries Integrase Inhibitors Market Size, 2017-2028
  6.5.9 Benelux Integrase Inhibitors Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Integrase Inhibitors Revenue, 2017-2028
  6.6.2 By Region - Asia Integrase Inhibitors Sales, 2017-2028
  6.6.3 China Integrase Inhibitors Market Size, 2017-2028
  6.6.4 Japan Integrase Inhibitors Market Size, 2017-2028
  6.6.5 South Korea Integrase Inhibitors Market Size, 2017-2028
  6.6.6 Southeast Asia Integrase Inhibitors Market Size, 2017-2028
  6.6.7 India Integrase Inhibitors Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Integrase Inhibitors Revenue, 2017-2028
  6.7.2 By Country - South America Integrase Inhibitors Sales, 2017-2028
  6.7.3 Brazil Integrase Inhibitors Market Size, 2017-2028
  6.7.4 Argentina Integrase Inhibitors Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Integrase Inhibitors Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Integrase Inhibitors Sales, 2017-2028
  6.8.3 Turkey Integrase Inhibitors Market Size, 2017-2028
  6.8.4 Israel Integrase Inhibitors Market Size, 2017-2028
  6.8.5 Saudi Arabia Integrase Inhibitors Market Size, 2017-2028
  6.8.6 UAE Integrase Inhibitors Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Integrase Inhibitors Major Product Offerings
  7.1.4 Merck Integrase Inhibitors Sales and Revenue in Global (2017-2022)
  7.1.5 Merck Key News
7.2 GlaxoSmithKline
  7.2.1 GlaxoSmithKline Corporate Summary
  7.2.2 GlaxoSmithKline Business Overview
  7.2.3 GlaxoSmithKline Integrase Inhibitors Major Product Offerings
  7.2.4 GlaxoSmithKline Integrase Inhibitors Sales and Revenue in Global (2017-2022)
  7.2.5 GlaxoSmithKline Key News
7.3 Hetero Drugs
  7.3.1 Hetero Drugs Corporate Summary
  7.3.2 Hetero Drugs Business Overview
  7.3.3 Hetero Drugs Integrase Inhibitors Major Product Offerings
  7.3.4 Hetero Drugs Integrase Inhibitors Sales and Revenue in Global (2017-2022)
  7.3.5 Hetero Drugs Key News
7.4 Mylan
  7.4.1 Mylan Corporate Summary
  7.4.2 Mylan Business Overview
  7.4.3 Mylan Integrase Inhibitors Major Product Offerings
  7.4.4 Mylan Integrase Inhibitors Sales and Revenue in Global (2017-2022)
  7.4.5 Mylan Key News
7.5 Aurobindo Pharma
  7.5.1 Aurobindo Pharma Corporate Summary
  7.5.2 Aurobindo Pharma Business Overview
  7.5.3 Aurobindo Pharma Integrase Inhibitors Major Product Offerings
  7.5.4 Aurobindo Pharma Integrase Inhibitors Sales and Revenue in Global (2017-2022)
  7.5.5 Aurobindo Pharma Key News
7.6 Cipla
  7.6.1 Cipla Corporate Summary
  7.6.2 Cipla Business Overview
  7.6.3 Cipla Integrase Inhibitors Major Product Offerings
  7.6.4 Cipla Integrase Inhibitors Sales and Revenue in Global (2017-2022)
  7.6.5 Cipla Key News
7.7 Laurus Labs
  7.7.1 Laurus Labs Corporate Summary
  7.7.2 Laurus Labs Business Overview
  7.7.3 Laurus Labs Integrase Inhibitors Major Product Offerings
  7.7.4 Laurus Labs Integrase Inhibitors Sales and Revenue in Global (2017-2022)
  7.7.5 Laurus Labs Key News
7.8 Gilead Sciences
  7.8.1 Gilead Sciences Corporate Summary
  7.8.2 Gilead Sciences Business Overview
  7.8.3 Gilead Sciences Integrase Inhibitors Major Product Offerings
  7.8.4 Gilead Sciences Integrase Inhibitors Sales and Revenue in Global (2017-2022)
  7.8.5 Gilead Sciences Key News
7.9 Micro Labs
  7.9.1 Micro Labs Corporate Summary
  7.9.2 Micro Labs Business Overview
  7.9.3 Micro Labs Integrase Inhibitors Major Product Offerings
  7.9.4 Micro Labs Integrase Inhibitors Sales and Revenue in Global (2017-2022)
  7.9.5 Micro Labs Key News

8 GLOBAL INTEGRASE INHIBITORS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Integrase Inhibitors Production Capacity, 2017-2028
8.2 Integrase Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Integrase Inhibitors Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 INTEGRASE INHIBITORS SUPPLY CHAIN ANALYSIS

10.1 Integrase Inhibitors Industry Value Chain
10.2 Integrase Inhibitors Upstream Market
10.3 Integrase Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Integrase Inhibitors Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Integrase Inhibitors in Global Market
Table 2. Top Integrase Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Integrase Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Integrase Inhibitors Revenue Share by Companies, 2017-2022
Table 5. Global Integrase Inhibitors Sales by Companies, (K Units), 2017-2022
Table 6. Global Integrase Inhibitors Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Integrase Inhibitors Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Integrase Inhibitors Product Type
Table 9. List of Global Tier 1 Integrase Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Integrase Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Integrase Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Integrase Inhibitors Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Integrase Inhibitors Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Integrase Inhibitors Sales (K Units), 2017-2022
Table 15. By Type - Global Integrase Inhibitors Sales (K Units), 2023-2028
Table 16. By Application – Global Integrase Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Integrase Inhibitors Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Integrase Inhibitors Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Integrase Inhibitors Sales (K Units), 2017-2022
Table 20. By Application - Global Integrase Inhibitors Sales (K Units), 2023-2028
Table 21. By Region – Global Integrase Inhibitors Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Integrase Inhibitors Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Integrase Inhibitors Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Integrase Inhibitors Sales (K Units), 2017-2022
Table 25. By Region - Global Integrase Inhibitors Sales (K Units), 2023-2028
Table 26. By Country - North America Integrase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Integrase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Integrase Inhibitors Sales, (K Units), 2017-2022
Table 29. By Country - North America Integrase Inhibitors Sales, (K Units), 2023-2028
Table 30. By Country - Europe Integrase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Integrase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Integrase Inhibitors Sales, (K Units), 2017-2022
Table 33. By Country - Europe Integrase Inhibitors Sales, (K Units), 2023-2028
Table 34. By Region - Asia Integrase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Integrase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Integrase Inhibitors Sales, (K Units), 2017-2022
Table 37. By Region - Asia Integrase Inhibitors Sales, (K Units), 2023-2028
Table 38. By Country - South America Integrase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Integrase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Integrase Inhibitors Sales, (K Units), 2017-2022
Table 41. By Country - South America Integrase Inhibitors Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Integrase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Integrase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Integrase Inhibitors Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Integrase Inhibitors Sales, (K Units), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Integrase Inhibitors Product Offerings
Table 48. Merck Integrase Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. GlaxoSmithKline Corporate Summary
Table 50. GlaxoSmithKline Integrase Inhibitors Product Offerings
Table 51. GlaxoSmithKline Integrase Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Hetero Drugs Corporate Summary
Table 53. Hetero Drugs Integrase Inhibitors Product Offerings
Table 54. Hetero Drugs Integrase Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Mylan Corporate Summary
Table 56. Mylan Integrase Inhibitors Product Offerings
Table 57. Mylan Integrase Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Aurobindo Pharma Corporate Summary
Table 59. Aurobindo Pharma Integrase Inhibitors Product Offerings
Table 60. Aurobindo Pharma Integrase Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Cipla Corporate Summary
Table 62. Cipla Integrase Inhibitors Product Offerings
Table 63. Cipla Integrase Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Laurus Labs Corporate Summary
Table 65. Laurus Labs Integrase Inhibitors Product Offerings
Table 66. Laurus Labs Integrase Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Gilead Sciences Corporate Summary
Table 68. Gilead Sciences Integrase Inhibitors Product Offerings
Table 69. Gilead Sciences Integrase Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Micro Labs Corporate Summary
Table 71. Micro Labs Integrase Inhibitors Product Offerings
Table 72. Micro Labs Integrase Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Integrase Inhibitors Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Integrase Inhibitors Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Integrase Inhibitors Production by Region, 2017-2022 (K Units)
Table 76. Global Integrase Inhibitors Production by Region, 2023-2028 (K Units)
Table 77. Integrase Inhibitors Market Opportunities & Trends in Global Market
Table 78. Integrase Inhibitors Market Drivers in Global Market
Table 79. Integrase Inhibitors Market Restraints in Global Market
Table 80. Integrase Inhibitors Raw Materials
Table 81. Integrase Inhibitors Raw Materials Suppliers in Global Market
Table 82. Typical Integrase Inhibitors Downstream
Table 83. Integrase Inhibitors Downstream Clients in Global Market
Table 84. Integrase Inhibitors Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Integrase Inhibitors Segment by Type
Figure 2. Integrase Inhibitors Segment by Application
Figure 3. Global Integrase Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Integrase Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Integrase Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. Integrase Inhibitors Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Integrase Inhibitors Revenue in 2021
Figure 9. By Type - Global Integrase Inhibitors Sales Market Share, 2017-2028
Figure 10. By Type - Global Integrase Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Type - Global Integrase Inhibitors Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Integrase Inhibitors Sales Market Share, 2017-2028
Figure 13. By Application - Global Integrase Inhibitors Revenue Market Share, 2017-2028
Figure 14. By Application - Global Integrase Inhibitors Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Integrase Inhibitors Sales Market Share, 2017-2028
Figure 16. By Region - Global Integrase Inhibitors Revenue Market Share, 2017-2028
Figure 17. By Country - North America Integrase Inhibitors Revenue Market Share, 2017-2028
Figure 18. By Country - North America Integrase Inhibitors Sales Market Share, 2017-2028
Figure 19. US Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Integrase Inhibitors Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Integrase Inhibitors Sales Market Share, 2017-2028
Figure 24. Germany Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. France Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Integrase Inhibitors Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Integrase Inhibitors Sales Market Share, 2017-2028
Figure 33. China Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. India Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Integrase Inhibitors Revenue Market Share, 2017-2028
Figure 39. By Country - South America Integrase Inhibitors Sales Market Share, 2017-2028
Figure 40. Brazil Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Integrase Inhibitors Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Integrase Inhibitors Sales Market Share, 2017-2028
Figure 44. Turkey Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Integrase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 48. Global Integrase Inhibitors Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Integrase Inhibitors by Region, 2021 VS 2028
Figure 50. Integrase Inhibitors Industry Value Chain
Figure 51. Marketing Channels